Cost-effectiveness analysis of cervical cancer examination program in Jiangsu Province
LIU Na, WANG Xudong, LUO Can
The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Jiangsu Women and Children Health Hospital, Department of Health Care, Nanjing, Jiangsu, 210036
Abstract：Objective The study aimed to understand the cost-effectiveness of cervical cancer examination program in Jiangsu province, and to provide reference for continuous improvement of the program. Methods The data were based on the quarterly statistical table of cervical cancer examination from 2009 to 2019. The detection rate of cervical precancerous lesions and cervical cancer increased year by year. In addition, the early detection cost index decreased from 25.7 in 2009 to 3.6 in 2019. The detection rate of cervical precancerous lesions, the detection rate of cervical cancer and the early detection cost index were adopted to evaluate the effect of the project. Results A growing number of people took part in the cervical cancer examination program from 2009 to 2019, and the detection rate of cervical precancerous lesions and cervical cancer and the early detection cost index varied in different regions. Conclusion The cervical cancer examination program in Jiangsu province has achieved good cost-effectiveness, whereas more detailed analysis should be carried out through the improvement of information system, in order to explore the specified screening strategies, which may benefit more people.
刘娜, 王绪东, 罗璨. 江苏省妇女宫颈癌检查项目检查成本效果初步分析[J]. 中国生育健康杂志, 2023, 34(3): 223-227.
LIU Na, WANG Xudong, LUO Can. Cost-effectiveness analysis of cervical cancer examination program in Jiangsu Province. Chinese Journal of Reproductive Health, 2023, 34(3): 223-227.
1 Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin,2018,68:394-424. 2 徐洁.宫颈癌筛查及预防的研究进展.医学信息,2018,31:70-73. 3 Canfell K,Sitas F,Beral V.Cervical cancer in Australia and the United Kingdom:comparison of screening policy and uptake,and cancer incidence and mortality.Med J Aust,2006,185:482-486. 4 Saraiya M,Ahmed F,Krishnan S,et al.Cervical cancer incidence in a prevaccine era in the United States,1998-2002.Obstet Gynecol,2007,109:360-370. 5 Arbyn M,Weiderpass E,Capocaccia R.Effect of screening on deaths from cervical cancer in Sweden.BMJ,2012,344:e804. 6 Mezei AK,Armstrong HL,Pedersen HN,et al.Cost -effectiveness of cervical cancer screening methods in low and middle-income countries:A systematic review.IntJ Cancer,2017,141:437-446. 7 何嫒萍,匡真良,莫凤志,等.广西梧州农村妇女宫颈癌careHPV筛查方案的卫生经济学评价.实用妇科内分泌电子杂志,2019,6:48-50. 8 王佳俣,刘桂兰,赵铭宇,等.黑龙江省大兴安岭地区宫颈癌筛查方案的成本-效果分析.中国卫生经济,2018,37:84-86. 9 揭俊钦,金龙妹,陈丹妮,等.宫颈癌筛查方案的成本效果评价:基于江浙沪地区.中国卫生资源,2019,22:175-179; 203. 10 王玉莹,王兆京,张瑜,等.中国农村15种子宫颈癌筛查方案的卫生经济学评价.中华妇产科杂志,2019,54:840-847. 11 林耀泉,方俊群,谭芳,等.贫困县宫颈癌筛查成本效益分析研究.实用预防医学,2016,23:576-578. 12 卫生部.卫生部/全国妇联关于印发《农村妇女“两癌”检查项目管理方案》的通知(卫妇社发〔2009〕61号).http://www.nhc.gov.cn/fys/s3581/200906/cd3c33a7ad624a50b8100b262041dabe.shtml. 13 中华人民共和国国家卫生健康委员会.农村妇女“两癌”检查项目管理方案(2015年版).http://www.nhc.gov.cn/jkfpwlz/zcwj1ge/201902/602bbe4b1de24410ad355f38d9b4bfe4.shtml. 14 江苏统计局.江苏统计年鉴2020.http://tj.jiangsu.gov.cn/2020/indexc.htm. 15 董志伟,乔友林,王贵齐,等.癌症早诊早治工作评价指标的探讨.中国肿瘤,2010,19:633-638. 16 石菊芳,代敏.中国癌症筛查的卫生经济学评价.中华预防医学杂志,2017,51:107-111. 17 Goldie SJ,Gaffikin L,Goldhaber-Fiebert JD,et al.Cost-effectiveness of cervical-cancer screening in five developing countries.J new Med,2005,353:2158-2168. 18 闫菊娥,杜蕾蕾,耿顺利,等.陕西省农村妇女宫颈癌筛查方案的卫生经济学评价.中国卫生经济,2016,35:91-94. 19 应倩,夏庆民,郑荣寿,等.中国2009年宫颈癌发病与死亡分析.中国肿瘤,2013,22:612-616. 20 闫菊娥,廖胜敏,王丹.陕西省农村妇女宫颈癌检查成本效果分析.中国卫生事业管理,2015,32:138-141.
